Skip to Main Content
The ever-increasing cost of healthcare and the aging of population are driving the development of diagnostic tests and drug delivery systems that determine an individual's therapeutic responsiveness and enable a more efficient therapy, saving healthcare dollars and giving patients better choices. The targeted personalized medicine also represents a huge market (estimated at about $232 billion for the US only today) with an annual growth rate of 11% in the coming years. Besides the regulatory and new business models to be developed, one of the many challenges ahead for this to happen, lies in the various new technologies to bring together for the successful realization and production of the devices required for a truly personalized medicine.
Date of Conference: 20-24 Feb. 2011